Chemical industry – Page 45
-
BusinessBayer and J&J lose first blood thinner lawsuit
US jury fines Xarelto makers $27.8 million for downplaying drug risks
-
BusinessEU extends glyphosate licence by 5 years
Extending herbicide’s approval until December 2022 has pleased neither industry nor environmental campaigners
-
BusinessSomething fishy about eating insects
While insects as human food remain a novelty in the West, fly larvae grown on human food waste could soon become an important protein source for fish farms
-
BusinessMerck & Co and Qiagen to build UK research hubs
Almost 2000 jobs to be created at research centres in Manchester and London
-
BusinessEuropean drug regulator heads to Amsterdam
Brexit drives EMA to relocate, taking hundreds of jobs and significant expertise away from UK
-
BusinessRussia backs new research cluster
Government touts high-tech science area as Russia’s answer to Silicon Valley
-
OpinionBeyond buckets and batches
Embracing flow chemistry means leaving behind some faithful friends
-
-
BusinessTargeting rare diseases
Is working on genetic mutations that affect only a few in every thousand people risky?
-
BusinessBayer forms cancer-drug partnership with Loxo
Alliance could see Loxo net up to $1.55bn in upfront and milestone payments
-
NewsRepublican tax bill backed by industry but not science
Chemical industry says tax overhaul will be fairer, but science groups warn that it will harm research
-
FeatureStaying one step ahead of the game
Clare Sansom examines the need for agile drug development when tackling emerging viral disease outbreaks
-
BusinessChina clamps down on polluting factories
Thousands of factories face closure or sanctions as authorities exercise new powers to curb air and water pollution
-
BusinessChina moves in on US shale gas
Alaska and West Virginia have welcomed investment from Chinese entities to develop US shale resources
-
BusinessIndia's science start-ups
A growing community of entrepreneurs are overcoming cultural and infrastructure barriers to commercialise their research
-
BusinessChuck Norris versus gadolinium
US action star is suing 11 drug firms for $10m, claiming his wife was poisoned by gadolinium from her MRIs
-
OpinionThe value of quantification
A skills gap is emerging in organic synthesis that needs to be closed
-
BusinessValeant relinquishes female libido drug
Struggling firm is returning Sprout Pharmaceuticals subsidiary to original shareholders to resolve dispute over marketing
-
BusinessGenerics firms Amneal and Impax to merge
Deal continues consolidation trend, based on portfolio expansion and simplifying supply chains
-
BusinessNovartis to buy AAA for radioligand cancer drugs
$3.9bn deal follows European approval of Advanced Accelerator Applications’ first-in-class radionuclide drug Lutathera